Radiation oncology firm Accuray has secured Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for its Radixact treatment delivery system, Accuray Precision treatment planning system and iDMS data management system.
The combination of the treatment delivery system and software solutions is expected to allow clinicians to provide accurate treatment to a wide range of cancer patients as well as to those undergoing retreatment.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Radixact system is a fully-integrated, simplified adaptive treatment planning solution, which facilitates routine adjustment of treatment plans according to the changes in tumour size, shape and location.
Accuray Japan president and general manager Juki Hozumi said: "With the introduction of the Radixact System, we are demonstrating significant progress in fulfilling on this promise.
"This new, mainstream System enables clinicians to deliver the highly sculpted doses for precise, customised treatments the previous TomoTherapy platform was known for, faster, enabling the treatment of more patients every day."
The newly approved advanced radiation therapy system is an easy to use and reliable device.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe system employs a linear accelerator, low-dose fan beam MVCT imaging and a helical treatment mode to enable clinicians to offer individualised dose distributions for all kinds of tumours.
According to a feedback received by the firm from its customers, Radixact system aids in providing precise radiation therapy to more patients in comparitively less time.
The system is now available in Japan, in addition to certain markets in the European Union and the US.
